Logistics management provides greater efficiency, governance and compliance

被引:13
作者
Ferrara, Francesco [1 ]
Santilli, Priscilla [1 ]
Vitiello, Antonio [1 ]
Forte, Giampiero [2 ]
D'Aiuto, Vilma [1 ]
机构
[1] Usl Umbria 1, Pharmaceut Dept, A Migliorati St, I-06132 Perugia, Italy
[2] Asl Roma 5, Pharmaceut Dept, Rome, Italy
关键词
Assessment; Clinical; Direct distribution; Governance; Health System; Logistic; Pharmacy; Sustainability; Technology;
D O I
10.1007/s11096-021-01283-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
During the 2020 Congress of the Italian Society of Hospital Pharmacy (Sifo 2020), there was a heated debate about whether it is more convenient to dispense healthcare directly in hospitals and public facilities, or indirectly, through the use of external private pharmacies. The former solution is called "direct dispensing" (DD), while the latter is called "dispensing on commission" (DPC). The strengths and advantages of DD over DPC are many: greater therapeutic appropriateness due to direct control of treatment plans, cost savings from external commissions, and greater clinical sharing of treatment by all healthcare personnel. The main weakness is the organization of a complex warehouse. As the number of chronic patients and advanced therapies increases, direct care requires a new structure and logistics system to manage large administrative, accounting, and information flows. The purpose of this article is to compare the two logistic models implemented in Italy in order to structure a computerized model that can increase the efficiency of the National Health System (NHS).
引用
收藏
页码:1431 / 1435
页数:5
相关论文
共 19 条
[1]  
CIACCIA A, 2020, BOLL SOC ITAL FARM O, V66, P346, DOI DOI 10.1704/3529.35177
[2]   Remdesivir and COVID-19 [J].
Ferrara, Francesco ;
La Porta, Raffaele ;
D'Aiuto, Vilma ;
Vitiello, Antonio .
IRISH JOURNAL OF MEDICAL SCIENCE, 2021, 190 (03) :1237-1238
[3]   Potential pharmacological approach in the regulation of angiotensin-II conversion enzyme and dipeptidyl-peptidase 4 in diabetic COVID-19 patients [J].
Ferrara, Francesco ;
Vitiello, Antonio .
ITALIAN JOURNAL OF MEDICINE, 2021, 15 (01) :53-55
[4]   From HTA to HTCLA: The Clinic and Logistics to Support Health Technology Assessments [J].
Ferrara, Francesco ;
Santilli, Priscilla ;
Vitiello, Antonio ;
D'Aiuto, Vilma .
HOSPITAL PHARMACY, 2022, 57 (01) :5-6
[5]  
Ferrara Francesco, 2021, Recenti Progressi in Medicina, V112, P219, DOI 10.1701/3565.35462
[6]   Efficacy of synthetic glucocorticoids in COVID-19 endothelites [J].
Ferrara, Francesco ;
Vitiello, Antonio .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2021, 394 (05) :1003-1007
[7]   Are multiple sclerosis therapies safe in severe acute respiratory syndrome coronavirus 2 times? [J].
Ferrara, Francesco ;
La Porta, Raffaele ;
Santilli, Priscilla ;
D'Aiuto, Vilma ;
Vitiello, Antonio .
INDIAN JOURNAL OF PHARMACOLOGY, 2020, 52 (05) :441-442
[8]   Antirheumatic in SARS-CoV-2: benefit or risk? [J].
Ferrara, Francesco .
ITALIAN JOURNAL OF MEDICINE, 2020, 14 (02) :114-115
[9]   The added value of pirfenidone to fight inflammation and fibrotic state induced by SARS-CoV-2 Anti-inflammatory and anti-fibrotic therapy could solve the lung complications of the infection? [J].
Ferrara, Francesco ;
Granata, Giovanni ;
Pelliccia, Chiara ;
La Porta, Raffaele ;
Vitiello, Antonio .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 76 (11) :1615-1618
[10]  
Italian Ministry of Health, GUID PREP TRANSM FIL